March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Talha Badar: Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL
Mar 1, 2025, 12:10

Talha Badar: Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL

Talha Badar, Hematology Oncology based in Mayo Clinic, shared an article by Renato Bassan, et al. on X:

“Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study.

Upfront Blina after C3 ad C6 of consolidation, risk-adapted. Primary endpoint MRD-ve CR Results: 93% MRD-ve, 3 yrs OS blina treated pts 91%.”

Talha Badar: Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL

Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study.

Authors: Renato Bassan, et al.

Talha Badar: Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL